메뉴 건너뛰기




Volumn 26, Issue 12, 1996, Pages 1186-1188

Profound decrease of in vivo formation of thromboxane during oestrogen therapy

Author keywords

Formation; Male; Oestrogens; Prostacyclin; Thromboxane

Indexed keywords

ESTROGEN; PROSTACYCLIN; THROMBOXANE;

EID: 0030442482     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.950606.x     Document Type: Article
Times cited : (9)

References (18)
  • 1
    • 0014138538 scopus 로고
    • Carcinoma of the prostate: Treatment comparisons
    • Veterans Administration Cooperative Urological Research Group. Carcinoma of the prostate: treatment comparisons. J Urol 1967;98:516-22.
    • (1967) J Urol , vol.98 , pp. 516-522
  • 2
    • 0022469720 scopus 로고
    • Orchidectomy versus oestrogen tor prostatic cancer: Cardiovascular effects
    • Henriksson P, Edhag O. Orchidectomy versus oestrogen tor prostatic cancer: cardiovascular effects. Br Med J 1986;93:413-5.
    • (1986) Br Med J , vol.93 , pp. 413-415
    • Henriksson, P.1    Edhag, O.2
  • 3
    • 0026458371 scopus 로고
    • Hormone therapy to prevent disease and prolong life in postmenopausal women
    • Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
    • (1992) Ann Intern Med , vol.117 , pp. 1016-1037
    • Grady, D.1    Rubin, S.M.2    Petitti, D.B.3
  • 4
    • 0018150863 scopus 로고
    • Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogen and progestins
    • Bradly DD, Wingerd J, Petitti DB, Krauss RM, Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogen and progestins. N Engl J Med 1978;299:17-20.
    • (1978) N Engl J Med , vol.299 , pp. 17-20
    • Bradly, D.D.1    Wingerd, J.2    Petitti, D.B.3    Krauss, R.M.4    Ramcharan, S.5
  • 5
    • 0018749716 scopus 로고
    • Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use
    • Wallace RB, Hoover J, Barrett-Conner E et al. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Lancet 1979;2:111-15.
    • (1979) Lancet , vol.2 , pp. 111-115
    • Wallace, R.B.1    Hoover, J.2    Barrett-Conner, E.3
  • 6
    • 0024418329 scopus 로고
    • Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma
    • Eriksson M, Berglund L, Rudling M, Henriksson P, Angelin B. Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma. J Clin Invest 1989;84:802-10.
    • (1989) J Clin Invest , vol.84 , pp. 802-810
    • Eriksson, M.1    Berglund, L.2    Rudling, M.3    Henriksson, P.4    Angelin, B.5
  • 7
    • 0026628106 scopus 로고
    • Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma
    • Henriksson P, Angelin B, Berglund L. Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest 1989;89:1166-77.
    • (1989) J Clin Invest , vol.89 , pp. 1166-1177
    • Henriksson, P.1    Angelin, B.2    Berglund, L.3
  • 8
    • 0026035002 scopus 로고
    • Plasma Lp (a) concentration after oestrogen and progestagen in postmenopausal women
    • M Soma, R Fumagalli, R Paoletti et al. Plasma Lp (a) concentration after oestrogen and progestagen in postmenopausal women. Lancet 1991;337:612.
    • (1991) Lancet , vol.337 , pp. 612
    • Soma, M.1    Fumagalli, R.2    Paoletti, R.3
  • 9
    • 0024263403 scopus 로고
    • Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate
    • Henriksson P, Eriksson A, Stege R et al. Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate. Prostate 1988;13:257-61.
    • (1988) Prostate , vol.13 , pp. 257-261
    • Henriksson, P.1    Eriksson, A.2    Stege, R.3
  • 10
    • 0022913802 scopus 로고
    • Activators and inhibitors of coagulation and fibrinolysis in patients with prostatic cancer treated with oestrogen or orchidectomy
    • Henriksson P, Blombäck M, Bratt G, Edhag O, Eriksson A. Activators and inhibitors of coagulation and fibrinolysis in patients with prostatic cancer treated with oestrogen or orchidectomy. Thromb Res 1986;44:783-91.
    • (1986) Thromb Res , vol.44 , pp. 783-791
    • Henriksson, P.1    Blombäck, M.2    Bratt, G.3    Edhag, O.4    Eriksson, A.5
  • 11
    • 0024446399 scopus 로고
    • Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer
    • Henriksson P, Blombäck M, Bratt G. Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer. Med Oncol Tumour Pharmacother 1989;6:219-25.
    • (1989) Med Oncol Tumour Pharmacother , vol.6 , pp. 219-225
    • Henriksson, P.1    Blombäck, M.2    Bratt, G.3
  • 12
    • 0019433760 scopus 로고
    • The effects of orchidectomy, estrogen and cyproterone acetate on the antithrombin III concentrations in carcinoma of the prostate
    • Varenhorst E, Wallentin L, Risberg B. The effects of orchidectomy, estrogen and cyproterone acetate on the antithrombin III concentrations in carcinoma of the prostate. Urol Res 1981;9:25-8.
    • (1981) Urol Res , vol.9 , pp. 25-28
    • Varenhorst, E.1    Wallentin, L.2    Risberg, B.3
  • 13
    • 0022469720 scopus 로고
    • Effects of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma
    • Henriksson P, Blombäck M, Eriksson A, Stege R, Carlström K. Effects of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma. Br Med J 1986;293:413-5.
    • (1986) Br Med J , vol.293 , pp. 413-415
    • Henriksson, P.1    Blombäck, M.2    Eriksson, A.3    Stege, R.4    Carlström, K.5
  • 14
    • 0021266160 scopus 로고
    • 1α and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs
    • 1α and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs. Prostagland 1984;28:139-54.
    • (1984) Prostagland , vol.28 , pp. 139-154
    • Vesterqvist, O.1    Green, K.2
  • 16
    • 0024800706 scopus 로고
    • Drug interactions with the in vivo synthesis of thromboxane and prostacyclin
    • Gréen K, Vesterqvist O. Drug interactions with the in vivo synthesis of thromboxane and prostacyclin. Drug Metabol Drug Interact 1989;7:321-51.
    • (1989) Drug Metabol Drug Interact , vol.7 , pp. 321-351
    • Gréen, K.1    Vesterqvist, O.2
  • 17
    • 0025100872 scopus 로고
    • Experimental atherosclerosis: Effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation
    • Fogelberg M, Vesterqvist O, Diczfalusy U, Henriksson P. Experimental atherosclerosis: effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation. Eur J Clin Invest 1990;20:105-10.
    • (1990) Eur J Clin Invest , vol.20 , pp. 105-110
    • Fogelberg, M.1    Vesterqvist, O.2    Diczfalusy, U.3    Henriksson, P.4
  • 18
    • 0027991286 scopus 로고
    • Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets
    • Matsuda K, Ruff A, Morinelli TA, Mathur RS, Halushka PV. Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol 1994;267:H887-93.
    • (1994) Am J Physiol , vol.267
    • Matsuda, K.1    Ruff, A.2    Morinelli, T.A.3    Mathur, R.S.4    Halushka, P.V.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.